8:45am ET
Investing
Share Offerings Prompt Huge Insider Buying in These 3 Biotechs
Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.
Companies
/Healthcare
Immunovant Inc
Today · % change
24/7 Wall St. View
Fundamentals
Market Cap
$7.9B
EPS (TTM)
$-2.76
52-Week Range
$15 – $45
Street Target
$48.88
About Immunovant
Immunovant Inc is a New York-based biopharmaceutical company focused on developing innovative treatments for autoimmune diseases. Its main project, batoclimab, is a groundbreaking antibody aimed at conditions like myasthenia gravis, thyroid eye disease, and several others. As part of the Roivant Sciences family, Immunovant is at the forefront of addressing unmet medical needs in the autoimmune space.
